Utah Medical Products Inc (UTMD) income statement
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/305% below fair value
$72.24+0.22 (+0.31%)
Close on Nov 18, 2026Market cap $230.00MP/E 22.0Yield –
Utah Medical Products Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 57.9%
- Operating margin
- 28.4%
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 48.62
- Debt to equity
- 0.00
- Debt to assets
- 0.2%
- Cash to current liabilities
- 4228.4%
Valuation
- P/E ratio
- 22.0
- Price to sales
- 6.37
- Price to book
- 1.88
- Dividend yield
- –
See a number that looks wrong?